Pharma

NEC Orchestrating Future Fund invests in Aetion, a U.S.-based provider of healthcare analytics platforms

NEC Orchestrating Future Fund, an ecosystem-based corporate venture capital (CVC) fund, has invested in Aetion, Inc., a U.S.-based provider of healthcare platforms. In addition, NEC and Aetion have started discussions for collaboration in the Real World Data (RWD) / Real World Evidence (RWE) business in drug development. In recent years, the medical field has witnessed a growing demand for the utilization of RWD/RWE to evaluate the safety and efficacy of drug development and to enhance the efficiency of the development and approval processes. However, several challenges persist in leveraging RWD/RWE, including data collection, standardization of data quality and analytical methods, and regulatory compliance. Aetion is a global leader in RWE platforms. The Aetion Evidence Platform® (AEP) is utilized by numerous organizations worldwide, including pharmaceutical companies, regulatory authorities, insurers, and healthcare…